MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,240 Cr | ₹2,681 Cr | ₹2,190 Cr | ₹1,660 Cr | ₹1,228 Cr |
What is the latest Total Liabilities ratio of MARKSANS PHARMA ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹3,240 Cr |
Mar2024 | ₹2,681 Cr |
Mar2023 | ₹2,190 Cr |
Mar2022 | ₹1,660 Cr |
Mar2021 | ₹1,228 Cr |
How is Total Liabilities of MARKSANS PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,240 Cr | 20.84 | |
Mar2024 | ₹2,681 Cr | 22.40 | |
Mar2023 | ₹2,190 Cr | 31.94 | |
Mar2022 | ₹1,660 Cr | 35.19 | |
Mar2021 | ₹1,228 Cr | - |
Compare Total Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹9,564.8 Cr | -6.7% | -17.8% | 8.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -6.7% |
-17.8% |
8.2% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses